Clementine Spring-Giusti

Clementine Spring-Giusti has extensive experience in toxicology and pharmacology, currently serving as Head of Toxicology at Transgene since April 2004. In this role, responsibilities include the toxicological evaluation of immunotherapeutic products and the development of toxicological plans for first-in-man studies. Prior to this, Clementine held positions at Pierre Fabre, including Scientific Assessor for licensing-in and out, where evaluations of pharmacology, toxicology, and ADME for partnering opportunities were conducted, and ADME Outsourcing Studies Manager, where a new unit for ADME outsourcing was established. Clementine also contributed to early-stage drug development as Early ADME Manager. An academic background includes a PhD in Life Sciences with a focus on Biochemical Engineering from Université de Caen Normandie.